Table 1 Clinicopathological characteristics of the breast cancer patients according to lncATB expression
Characteristics | lncATB expression | χ 2 | P value | |
|---|---|---|---|---|
High n (%) | Low n (%) | |||
Age years | ||||
≤40 | 14 (15.2) | 4 (10.3) | 0.569 | 0.451 |
>40 | 78 (84.8) | 35 (89.7) | ||
Histology grade | ||||
I and II | 30 (32.6) | 22 (56.4) | 6.482 | 0.011 |
III | 62 (67.4) | 17 (43.6) | ||
Stage | ||||
I and II | 55 (59.8) | 30 (76.9) | 3.532 | 0.060 |
III and IV | 37 (40.2) | 9 (23.1) | ||
Tumour size | ||||
T0-T1 | 20 (21.7) | 9 (23.1) | 0.028 | 0.866 |
T2-T4 | 72 (78.3) | 30 (76.9) | ||
LN status | ||||
Negative | 38 (41.3) | 19 (48.7) | 0.612 | 0.434 |
Positive | 54 (58.7) | 20 (51.3) | ||
No. of LN metastasis | ||||
LN ≤ 3 | 63 (68.5) | 31 (79.5) | 5.965 | 0.051 |
3 <LN <10 | 12 (13.0) | 7 (17.9) | ||
LN ≥ 10 | 17 (18.5) | 1 (2.6) | ||
Distant metastasis | ||||
Negative | 74 (80.4) | 37 (94.9) | 4.413 | 0.036 |
Positive | 18 (19.6) | 2 (5.1) | ||
Ki67 | ||||
Negative | 7 (7.6) | 17 (43.6) | 23.696 | <0.001 |
Positive | 85 (92.4) | 22 (56.4) | ||
